Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy

AIDS

Volumn 25, Issue 5, 2011, Pages 701-705

  Bakanda, Celestin ^a   Birungi, Josephine ^a   Mwesigwa, Robert ^a   Ford, Nathan ^b,c   Cooper, Curtis L ^d   Au Yeung, Christopher ^e   Chan, Keith ^e   Nachega, Jean B ^f   Wood, Evan ^e   Hogg, Robert S ^b,e   Dybul, Mark ^g,h   Mills, Edward J ^a,e,i  

^a THE AIDS SUPPORT ORGANIZATION   (Uganda)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g GEORGETOWN UNIVERSITY LAW CENTER   (United States)

^h George W Bush Institute   (United States)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

Author keywords

antiretroviral therapy; elderly; HIV; older adults; survival

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; AGING; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL; UGANDA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 79952441005     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283437ed7     Document Type: Article

References (32)

1. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ 2010; 88:847-853; doi: 102471/ BLT10076349.
2. Schmid G, Williams B, Garcia-Calleja J, Miller C, Segar E, Southworth M, et al. The unexplored story of HIV and ageing. Bull World Health Organ 2009; 87:162-162A.
3. Zaba B, Todd J, Biraro S, Shafer L, Lutalo T, Ndyanabo A, et al. Diverse age patterns of HIV incidence rates in Africa [abstract]. In: Program and Abstracts of the 17th International AIDS Conference; 3-8 August 2008; Mexico City, Mexico.
4. Negin J, Wariero J, Cumming RG, Mutuo P, Pronyk PM. High rates of AIDS-related mortality among older adults in rural Kenya. J Acquir Immune Defic Syndr 2010; 55:239-244.
5. Justice AC. Treated HIV infection is a chronic disease: the case against cause of death analyses. Int J Epidemiol 2010; 39:146-148.
6. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367:817-824.
7. Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIVunrelated mortality. PLoS Med 2009; 6:e1000066.
8. May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 2010; 376:449-457.
9. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296:782-793. (Pubitemid 44223102)
10. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, Mathee S, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 2010; 24:563-572.
11. Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, et al. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS 2008; 22:2493-2499.
12. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al. Mortality and loss-to-follow-up during the pretreatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009; 9:290.
13. World Health Organization. WHOIS: definition of an older or elderly person. Health statistics and health information systems. 2010. http://wwwwhoint/healthinfo/survey/ageingdefnolder/ en/indexhtml.
14. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-129. (Pubitemid 34786200)
15. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009; 4:e5790.
16. Gilks WR, Richardson S, Spiegelhalter DJ. Markov chain Monte Carlo in practice. London, UK: Chapman and Hall; 1996.
17. R Development Core Team. R. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
18. Rothenberg R, Woelfel M, Stoneburnmer R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York city. N Engl J Med 1987; 317:1297-1302. (Pubitemid 17153010)
19. Ship J, Wolff A, Selik R. Epidemiology of acquired immune deficiency syndrome in persons aged 50 years or older. J Acquir Immune Defic Syndr 1991; 4:84-88.
20. Sutin D, Rose D, Mulvihill M, Taylor B. Survival of elderly patients with transfusion-related acquired immunodeficiency syndrome. J Am Geriatr Soc 1993; 41:214-216. (Pubitemid 23078106)
21. Bacchetti P, Osmond D, Chaisson R, Dritz S, Rutherford G, Swig L, Moss A. Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis 1988; 157:1044-1047.
22. Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 2005; 19:2009-2018. (Pubitemid 41669026)
23. Douek D, McFarland R, Keiser P, Gage E, Massey J, Haynes B, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 296:690-695. (Pubitemid 29003949)
24. Lederman M, McKinnis R, Kelleher D, Cutrell A, Mellows J, Neisler M, et al. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS 2000; 14:2635-2642. (Pubitemid 32118716)
25. Fair Wellons M, Sanders L, Edwards L, Bartlett J, Heald A, Schmader K. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc 2002; 50:603-607. (Pubitemid 34298746)
26. Tumbarello M, Rabagliati R, Donati K. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS 2003; 17:128-130.
27. Perez J, Moore R. Greater effect of highly active antiretroviral therapy on survival in people aged 50 years compared with younger people in an urban observational cohort. Clin Infect Dis 2003; 36:212-218. (Pubitemid 36143421)
28. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York city. Ann Intern Med 2006; 145:397-406. (Pubitemid 46768570)
29. Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47:542-553.
30. Justice A. Treated HIV infection is a chronic disease: the case against cause of death analyses. Int J Epidemiol 2010; 39:146-148.
31. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367:1335-1342.
32. DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised noninferiority trial. Lancet 2010; 375:123-131.